S. 1634 · 117th Congress
FDA Review of Efficacy of EERW Double-Blinds of Opioids Act
- Stage
- In committee
- Sponsor
- Joe Manchin
- Introduced
- 2021-05-13
- Latest action
- 2021-05-13 · Introduced in Senate
Subjects
Government studies and investigations
Health
Medical research
Drug, alcohol, tobacco use
Advisory bodies
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Drug trafficking and controlled substances